270 related articles for article (PubMed ID: 15082337)
1. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.
Wagner E; Kircheis R; Walker GF
Biomed Pharmacother; 2004 Apr; 58(3):152-61. PubMed ID: 15082337
[TBL] [Abstract][Full Text] [Related]
2. Targeting strategies in cancer gene therapy.
Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle and targeted systems for cancer therapy.
Brannon-Peppas L; Blanchette JO
Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
[TBL] [Abstract][Full Text] [Related]
5. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
Brumlik MJ; Daniel BJ; Waehler R; Curiel DT; Giles FJ; Curiel TJ
Expert Opin Drug Deliv; 2008 Jan; 5(1):87-103. PubMed ID: 18095930
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
Dorer DE; Nettelbeck DM
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
[TBL] [Abstract][Full Text] [Related]
7. Functional polymers for targeted delivery of nucleic acid drugs.
Mok H; Park TG
Macromol Biosci; 2009 Aug; 9(8):731-43. PubMed ID: 19655399
[TBL] [Abstract][Full Text] [Related]
8. To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?
Ogris M; Wagner E
Hum Gene Ther; 2011 Jul; 22(7):799-807. PubMed ID: 21563983
[TBL] [Abstract][Full Text] [Related]
9. Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy.
Hallaj-Nezhadi S; Lotfipour F; Dass CR
Pharmazie; 2010 Dec; 65(12):855-9. PubMed ID: 21284252
[TBL] [Abstract][Full Text] [Related]
10. New insights into the molecular biology and targeted therapy of cutaneous T-cell lymphomas.
Klemke CD; Goerdt S; Schrama D; Becker JC
J Dtsch Dermatol Ges; 2006 May; 4(5):395-406. PubMed ID: 16686607
[TBL] [Abstract][Full Text] [Related]
11. Directed evolution for drug and nucleic acid delivery.
Hida K; Hanes J; Ostermeier M
Adv Drug Deliv Rev; 2007 Dec; 59(15):1562-78. PubMed ID: 17933418
[TBL] [Abstract][Full Text] [Related]
12. Radiation-guided drug delivery systems.
Stacy DR; Lu B; Hallahan DE
Expert Rev Anticancer Ther; 2004 Apr; 4(2):283-8. PubMed ID: 15056058
[TBL] [Abstract][Full Text] [Related]
13. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.
Kaneda Y
Expert Opin Drug Deliv; 2010 Sep; 7(9):1079-93. PubMed ID: 20716020
[TBL] [Abstract][Full Text] [Related]
14. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
Marcucci F; Lefoulon F
Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
[TBL] [Abstract][Full Text] [Related]
15. Selective or targeted gene/drug delivery for liver tumors: advantages and current status of local delivery.
Kim YI; Chung JW
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):791-802. PubMed ID: 19090739
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.
Snyder EL; Dowdy SF
Expert Opin Drug Deliv; 2005 Jan; 2(1):43-51. PubMed ID: 16296734
[TBL] [Abstract][Full Text] [Related]
17. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy developments for pancreatic cancer.
Bhattacharyya M; Lemoine NR
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
[TBL] [Abstract][Full Text] [Related]
19. Targeted drug delivery strategies to treat lung metastasis.
Bar J; Herbst RS; Onn A
Expert Opin Drug Deliv; 2009 Oct; 6(10):1003-16. PubMed ID: 19663628
[TBL] [Abstract][Full Text] [Related]
20. Active targeting schemes for nanoparticle systems in cancer therapeutics.
Byrne JD; Betancourt T; Brannon-Peppas L
Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
